Heterogeneity of human skin mast cells and human basophils

Skin Pharmacology and Physiology

Volumn 9, Issue 3, 1996, Pages 211-220

  Amon, Ulrich ^a   Dieckmann, Detlef ^a   Nitschke, Martin ^a   Von Stebut, Esther ^a   Gibbs, Bernhard F ^a   Wolff, Helmut H ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Human basophils; Protein kinase C; Signal transduction pathways; Skin mast cells

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3 [1 (3 AMINOPROPYL) 3 INDOLYL] 4 (1 METHYL 3 INDOLYL) 1H PYRROLE 2,5 DIONE; CALPHOSTIN C; HISTAMINE; IMMUNOGLOBULIN E; K 252A; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE INHIBITOR;

ARTICLE; BASOPHIL; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; EXOCYTOSIS; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAST CELL; NORMAL HUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BASOPHILS; EXOCYTOSIS; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; PROTEIN KINASE C; RATS; RATS, WISTAR; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SKIN;

EID: 0029875615     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211418     Document Type: Article

References (29)

1. Dekker LV, Parker PJ: Protein kinase C: A question of specificity. Trends Biochem Sei 1994; 19:73-77.
2. Wilkinson SE, Hallam TJ: Protein kinase C: Is its pivotal role in cellular activation overstated? Trends Pharmacol Sei 1994;15:53-57.
3. Warner JA, MacGlashan DW: Protein kinase C changes in human basophils. J Immunol 1989; 142:1669-1677.
4. Warner JA, MacGlashan DW: Signal transduction events in human basophils: A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phe-nylalanine. J Immunol 1990; 145: 1897-1905.
5. Ozawa K, Szallasi Z, Kazanietz MG, Blumberg PM. Mischak H, Mushinski JF, Beaven MA: Ca2+-dependent and Ca2+-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. J Biol Chem 1993;268:1749-1756.
6. Amon U, Nitschke M, Dieckmann D, Gibbs BF, Wehrhahn C, Wolff HH: Activation and inhibition of mediator release from skin mast cells: A review of in vitro experiments. Clin Exp Allergy 1994;24: 1098-1104.
7. Rothe MJ, Nowak M, Kerdel FA: The mast cell in health and disease. J Am Acad Dermatol 1990:23:615-623.
8. Massey WA: Pathogenesis and pharmacologic modulation of the cutaneous late-phase reaction. Ann Allergy 1993;71:578-584.
9. Amon U, von Stebut E, Dietz KR, Bauer FW, Wolf HH: Pharmacological studies on the role of protein kinase C in signal transduction of human basophils, Int Arch Allergy Immunol 1992;98:349-354.
10. Bergstrand H, Lundquist B, Karabe-las B, Michelsen P: Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor. J Pharmacol ExpTher 1992; 260:1028-1037.
11. White JR, Zembryki D, Hanna V, Mong S: Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: Stauro-sporine and K252a. Biochem Pharmacol 1990;40:447-456.
12. Amon U, Dietz KR: Protein kinase C: A target for anti-inflammatory therapy? Arch Dermatol Res 1992; 284:8-10.
13. 2+ ionophore. J Immunol 1989;143:2617-2625.
14. Massey WA, Cohan VL, MacGla-shan DW, Gitten SW, Kagey-Sobot-ka A, Lichtenstein LM, Warner JA: Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. 1. Pharmacologic inhibition. J Pharm Exp Ther 1991;258:824-829.
15. Okayama Y, Church MK: Drugs modifying the responses of mast cells and basophils; in Foreman JC fed: ImmunopharmacotogyofMast Cells and Basophils. The Handbook of Pharmacology. London, Academic Press, 1993, pp 139-152.
16. Amon U, von Stebut E, Subramanian N, Wolff HH: CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils. Pharmacology 1993;47:200-208.
17. Amon U, von Stebut E, Wolff HH: Pharmacological investigations with different protein kinase C inhibitors on IgE-dcpendent and IgE-indcpen-dent activation of human basophils. Agents Actions 1993;39:13-19.
18. Hofer HW, Schlatter S, Graefe M: Phosphorylation of phosphofructo-kinase by protein kinase C changes the allosteric properties of the enzyme. Biochem Biophys Res Com-mun 1985;129:892-897.
19. Davis PD, Hill CH, Keech E, Lawton G, Nixon JS; Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE: Potent selective inhibitors of protein kinase C. FEBS Lett 1989;259:61-63.
20. Elliot LH, Wilkinson SE, Sedgwick AD, Hill CH, Lawton G, Davis PD, Nixon JS: K252a is a potent and selective inhibitor of phosphorylase kinase. Biochem Biophys Res Com-mun 1990;171:148-154.
21. Kobayashi E, Nakano H, Morimoto M, Tamaoki T: Calphostin C (UCN 1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1989;159:548-553.
22. Toullec D, Pianetti P, Coste H, Bel-levergue P, Grand-Perret T, Aja-kane M, Baudet V, Boissin P, Bour-sier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J: The bisindolyl-malcidc GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;24: 15771-15781.
23. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y: Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982; 257:7847-7851.
24. Amon U, von Stcbut E, Wolff HH: Effects of protein kinase C activators on human basophils. Agents Actions 1993;38:C39-41.
25. Nishizuka Y: The family of protein kinase C for signal transduction. JAMA 1989;262:1826-1833.
26. Amon U, von Stebut E, von Gizycki U, Wolff HH: Control function of protein kinase C isozymes on leuko-triene generation from human basophils? Agents Actions 1994;41:C9-10.
27. Ozawa K, Yamada K, Kazanietz MG, Blumberg PM, Beaven MA: Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for cxocytosis in RBL-2H3 cells. J Biol Chem 1993,268:2280-2283.
28. Martiny-Baron G, Kazanietz MG, Mishak H, Blumberg PM, Kochs G, Hug H, Marmc D. Schachtele C: Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 1993;268: 9194-9197.
29. Andrejauskas-Buchdunger E, Re-genass U: Differential Inhibition of the epidermal growth factor-, platelet-derived growth factor-, and protein kinase C-mediated signal transduction pathways by the staurospo-rine derivative CGP 41251. Cancer Res 1992;52:5353-5358.